279 related articles for article (PubMed ID: 11256900)
1. Efficacy of standard ten millicurie dose of radio-iodine in management of autonomously functioning toxic thyroid nodules.
Sharma R; Bhatnagar A; Mondal A; Kashyap R; Khanna CM
J Assoc Physicians India; 1995 Mar; 43(3):167-9, 172. PubMed ID: 11256900
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
4. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
6. [Effect of iodine application during radioiodine therapy in patients with impending therapy failure].
Urbannek V; Schmidt M; Moka D; Hillger HW; Voth E; Wellner U; Schicha H
Nuklearmedizin; 2000; 39(4):108-12. PubMed ID: 10919161
[TBL] [Abstract][Full Text] [Related]
7. Standard dose 131I therapy for hyperthyroidism caused by autonomously functioning thyroid nodules.
Ng Tang Fui SC; Maisey MN
Clin Endocrinol (Oxf); 1979 Jan; 10(1):69-77. PubMed ID: 436306
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy.
Khanna CM; Magdam M; Ravishankar L; Dham DN; Chugh P
J Assoc Physicians India; 1995 Oct; 43(10):685-8. PubMed ID: 8773004
[TBL] [Abstract][Full Text] [Related]
9. Relevance of cause of hyperthyroidism in determining its management.
Veneman TF; Weymer M; Tjabbes T; van Haeften TW
Neth J Med; 1989 Dec; 35(5-6):303-8. PubMed ID: 2635287
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine.
Huysmans DA; Corstens FH; Kloppenborg PW
J Nucl Med; 1991 Jan; 32(1):27-30. PubMed ID: 1988632
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of large toxic multinodular goiters.
Hamburger JI; Hamburger SW
J Nucl Med; 1985 Aug; 26(8):888-92. PubMed ID: 2411889
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine treatment of 524 cats with hyperthyroidism.
Peterson ME; Becker DV
J Am Vet Med Assoc; 1995 Dec; 207(11):1422-8. PubMed ID: 7493869
[TBL] [Abstract][Full Text] [Related]
15. Unsuccessful radioiodine treatment of a non-toxic goiter: a case report.
Hartoft-Nielsen ML; Rasmussen AK; Friis E; Blichert-Toft M; Buhl T; Hesse B; Feldt-Rasmussen U
Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):72-5. PubMed ID: 15379783
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with (131)I of toxic multinodular goiter. Assessment of a fixed dose protocol].
Abós MD; Banzo J; Razola P; García F; Prats E
Rev Esp Med Nucl; 2000 Jun; 19(3):182-6. PubMed ID: 11062080
[TBL] [Abstract][Full Text] [Related]
18. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy.
Kahraman D; Keller C; Schneider C; Eschner W; Sudbrock F; Schmidt M; Schicha H; Dietlein M; Kobe C
Clin Endocrinol (Oxf); 2012 Feb; 76(2):297-303. PubMed ID: 21854403
[TBL] [Abstract][Full Text] [Related]
19. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
Guhlmann CA; Rendl J; Börner W
Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
[TBL] [Abstract][Full Text] [Related]
20. Current treatment of nodular goiter with hyperthyroidism (Plummer's disease): surgery versus radioiodine.
Kang AS; Grant CS; Thompson GB; van Heerden JA
Surgery; 2002 Dec; 132(6):916-23; discussion 923. PubMed ID: 12490836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
